|2003N-0573||Draft Animal Cloning Risk Assessment|
|FDA Comment Number :||EC412|
|Submitter :||Mr. Ray Damijonaitis||Date & Time:||01/03/2007 03:01:30|
|Organization :||Mr. Ray Damijonaitis|
|Category :||Individual Consumer|
| I am following your progress in Docket item 203N-0573.
As a consumer, it would seem to me that labeling a product as to its origins or technology of production is the prudent thing to do.
We have a history of introducing elements into our food and drug chain which were once deemed to benign, but were later found to be harmful.
The costs of such labelling are miniscule and will allow the consumer to be able to exercise their choice of adding newly developed products into their diets.
It is not the job of the FDA to ensure the economic viability of a new manufacturing process. Once a determination has bee made that an item is provisionally safe, labelling for at least five years should be the rule.